Sonoma Pharmaceuticals Q3 EPS $(0.08) Up From $(0.62) YoY, Sales $3.14M Up From $2.94M YoY
Sonoma Pharmaceuticals Q3 EPS $(0.08) Up From $(0.62) YoY, Sales $3.14M Up From $2.94M YoY
索諾瑪製藥第三季度每股收益爲0.08美元（0.08美元），高於同比增長0.62美元，銷售額爲314萬美元，同比增長294萬美元
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.08) per share. This is a 87.1 percent increase over losses of $(0.62) per share from the same period last year. The company reported $3.14 million in sales this quarter. This is a 6.59 percent increase over sales of $2.94 million the same period last year.
索諾瑪製藥（納斯達克股票代碼：SNOA）報告稱，季度每股虧損爲0.08美元。這比去年同期每股虧損0.62美元（0.62美元）增長了87.1％。該公司報告本季度銷售額爲314萬美元。這比去年同期294萬美元的銷售額增長了6.59％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。